WallStSmart
ZBH

Zimmer Biomet Holdings Inc

NYSE: ZBH · HEALTHCARE · MEDICAL DEVICES

$80.07
-3.30% today

Updated 2026-04-29

Market cap
$15.50B
P/E ratio
20.74
P/S ratio
1.84x
EPS (TTM)
$3.86
Dividend yield
1.16%
52W range
$80 – $107
Volume
2.2M

Zimmer Biomet Holdings Inc (ZBH) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+2.2%
Last 4 quarters
Revenue YoY growth
+10.9%
Most recent quarter
EPS YoY growth
+4.8%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.2%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+8.9%
2025-08-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-04$2.42+0.9%$86.18$88.73+3.0%
2025-10-30$1.90+1.1%$99.71$100.56+0.9%
2025-08-07$2.07+4.5%$91.15$99.26+8.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$2.40$2.42+0.9%$2.24B+10.9%
2025-09-30$1.88$1.90+1.1%$2.00B+9.7%
2025-06-30$1.98$2.07+4.5%$2.08B+7.0%
2025-03-31$1.77$1.81+2.3%$1.91B+1.1%
2024-12-31$2.29$2.31+0.9%$2.02B+4.3%
2024-09-30$1.74$1.74+0.0%$1.82B+4.0%
2024-06-30$1.99$2.01+1.0%$1.94B+3.9%
2024-03-31$1.87$1.94+3.7%$1.89B
2023-12-31$2.15$2.20+2.3%$1.94B
2023-09-30$1.60$1.65+3.1%$1.75B
2023-06-30$1.81$1.82+0.6%$1.87B

Frequently asked questions

Has Zimmer Biomet Holdings Inc beaten earnings estimates?
Zimmer Biomet Holdings Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +2.2% over the last 4 quarters.
How does ZBH stock react to earnings?
ZBH stock has moved an average of +4.2% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Zimmer Biomet Holdings Inc's revenue growth rate?
Zimmer Biomet Holdings Inc reported year-over-year revenue growth of +10.9% in its most recent quarter, with EPS growing +4.8% year-over-year.